Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yves Pirson

Showing results (51-60 of 67) with videos related to

Pageof 7
Sort By:
Kidney International|December 1, 2004
Comparison between siblings and twins supports a role for modifier genes in ADPKDAlexandre Persu, Michel Duyme, Yves Pirson, et al.
Blood|July 29, 2008
Factor H, membrane cofactor protein, and factor I mutations in patients with hemolysis, elevated liver enzymes, and low platelet count syndromeFadi Fakhouri, Mathieu Jablonski, Jacques Lepercq, et al.
Kidney International|January 13, 2012
Incidence of renal failure and nephroprotection by RAAS inhibition in heterozygous carriers of X-chromosomal and autosomal recessive Alport mutationsJohanna Temme, Frederick Peters, Katharina Lange, et al.
Kidney International Reports|June 2, 2018
Genotype and Outcome After Kidney Transplantation in Alport SyndromeValentine Gillion, Karin Dahan, Jean-Pierre Cosyns, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|June 13, 2014
Rituximab for minimal-change nephrotic syndrome in adulthood: predictive factors for response, long-term outcomes and toleranceJoëlle Guitard, Anne-Laure Hebral, Fadi Fakhouri, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 21, 2003
Mutations in human complement regulator, membrane cofactor protein (CD46), predispose to development of familial hemolytic uremic syndromeAnna Richards, Elizabeth J Kemp, M Kathryn Liszewski, et al.
Journal of the American Society of Nephrology : JASN|October 22, 2003
A cluster of mutations in the UMOD gene causes familial juvenile hyperuricemic nephropathy with abnormal expression of uromodulinKarin Dahan, Olivier Devuyst, Michèle Smaers, et al.
Kidney International|March 19, 2015
Autosomal-dominant polycystic kidney disease (ADPKD): executive summary from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies ConferenceArlene B Chapman, Olivier Devuyst, Kai-Uwe Eckardt, et al.
Plos Medicine|November 2, 2006
Atypical haemolytic uraemic syndrome associated with a hybrid complement geneJulian P Venables, Lisa Strain, Danny Routledge, et al.
Transplantation|November 12, 2015
Calcineurin Inhibitors Downregulate HNF-1β and May Affect the Outcome of HNF1B Patients After Renal TransplantationStanislas Faguer, Laure Esposito, Audrey Casemayou, et al.
Pageof 7

Showing results (51-60 of 67) with videos related to

Sort By:
Pageof 7
Kidney International|December 1, 2004
Comparison between siblings and twins supports a role for modifier genes in ADPKDAlexandre Persu, Michel Duyme, Yves Pirson, et al.
Blood|July 29, 2008
Factor H, membrane cofactor protein, and factor I mutations in patients with hemolysis, elevated liver enzymes, and low platelet count syndromeFadi Fakhouri, Mathieu Jablonski, Jacques Lepercq, et al.
Kidney International|January 13, 2012
Incidence of renal failure and nephroprotection by RAAS inhibition in heterozygous carriers of X-chromosomal and autosomal recessive Alport mutationsJohanna Temme, Frederick Peters, Katharina Lange, et al.
Kidney International Reports|June 2, 2018
Genotype and Outcome After Kidney Transplantation in Alport SyndromeValentine Gillion, Karin Dahan, Jean-Pierre Cosyns, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|June 13, 2014
Rituximab for minimal-change nephrotic syndrome in adulthood: predictive factors for response, long-term outcomes and toleranceJoëlle Guitard, Anne-Laure Hebral, Fadi Fakhouri, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 21, 2003
Mutations in human complement regulator, membrane cofactor protein (CD46), predispose to development of familial hemolytic uremic syndromeAnna Richards, Elizabeth J Kemp, M Kathryn Liszewski, et al.
Journal of the American Society of Nephrology : JASN|October 22, 2003
A cluster of mutations in the UMOD gene causes familial juvenile hyperuricemic nephropathy with abnormal expression of uromodulinKarin Dahan, Olivier Devuyst, Michèle Smaers, et al.
Kidney International|March 19, 2015
Autosomal-dominant polycystic kidney disease (ADPKD): executive summary from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies ConferenceArlene B Chapman, Olivier Devuyst, Kai-Uwe Eckardt, et al.
Plos Medicine|November 2, 2006
Atypical haemolytic uraemic syndrome associated with a hybrid complement geneJulian P Venables, Lisa Strain, Danny Routledge, et al.
Transplantation|November 12, 2015
Calcineurin Inhibitors Downregulate HNF-1β and May Affect the Outcome of HNF1B Patients After Renal TransplantationStanislas Faguer, Laure Esposito, Audrey Casemayou, et al.
Pageof 7